Andrew McPherson

Memorial Sloan Kettering Cancer Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

41h-index16.1kcitations163works3.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(74), Single-cell and spatial transcriptomics(44), Genomics and Phylogenetic Studies(18), Ovarian cancer diagnosis and treatment(12), Cancer-related molecular mechanisms research(11)

Publications161 total

End-to-end proteogenomics for discovery of cryptic and non-canonical cancer proteoforms using long-read transcriptomics and multi-dimensional proteomics
2026Open Access
End-to-end proteogenomics for discovery of cryptic and non-canonical cancer proteoforms using long-read transcriptomics and multi-dimensional proteomics
2026Open Access
Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancer
Nature Communications·2025Open Access
Enabling whole genome sequencing analysis from FFPE specimens in clinical oncology
Nature Communications·2025· 1 citedOpen Access
Integrating single-cell whole genome and transcriptome sequencing to track the clonal evolution of TP53-mutated myeloid neoplasms
Blood·2025
Genomics define neoplastic transformation in multiple myeloma precursor conditions
Blood·2025
Protocol for a multicentre randomised controlled trial of the Pharmacy Homeless Outreach Engagement Non-medical and Independent Prescriber (PHOENIx) intervention for people facing severe and multiple disadvantages
BMJ Open·2025Open Access
Genomics Define Malignant Transformation in Myeloma Precursor Conditions
Journal of Clinical Oncology·2025· 1 citedOpen Access
Tracking clonal evolution during treatment in ovarian cancer using cell-free DNA
Nature·2025· 4 citedOpen Access
A pilot randomised controlled trial of Tailored Intervention for people with moderate-to-severe Chronic Obstructive Pulmonary Disease and Co-morbidities delivered by Pharmacists and Consultant respiratory Physicians (TICC-PCP)
2025
End-to-end proteogenomics for discovery of cryptic and non-canonical cancer proteoforms using long-read transcriptomics and multi-dimensional proteomics
2025Open Access
Ongoing genome doubling shapes evolvability and immunity in ovarian cancer
Nature·2025· 18 citedOpen Access
Abstract B054: Identification of spatial motifs linked to tumor genotype using graph attention networks
Clinical Cancer Research·2025
FOXA2 promotes metastatic competence in small cell lung cancer
Nature Communications·2025· 5 citedOpen Access
Complementary modes of resistance to <i>EGFR</i> TKI in lung adenocarcinoma through MAPK activation and cellular plasticity
2025Open Access
Disrupted priming within draining lymph nodes drives immune quiescence in gastric cancer
2025Open Access
Abstract 6608: Integrating HCMI models and tumors with CCLE and TCGA: Advancing cancer modeling and precision oncology
Cancer Research·2025
Abstract 2856: Pks+ E. coli trigger intestinal stem cell plasticity and early onset colorectal cancer
Cancer Research·2025· 2 cited
Abstract 4005: Integrative clinical and molecular characterization of an international community resource of organoid models of human cancer
Cancer Research·2025
Abstract 3882: Patterns of genomic patient-model conservation and evolution in the Human Cancer Models Initiative (HCMI) next-generation cancer model resource
Cancer Research·2025
page 1 of 9Next →

Frequent Co-authors

Sohrab P. Shah(33), Samuel Aparício(23), Andrew Roth(16), Marco A. Marra(16), Daniel Lai(12), David G. Huntsman(11), Emma Laks(11), Carlos Caldas(10), Oscar M. Rueda(9), Ciara H. O’Flanagan(9), Gavin Ha(8), Richard A. Moore(8), Alejandra Bruna(8), Wendy Greenwood(8), Jessica N. McAlpine(8), Bernd Bodenmiller(8), Diljot Grewal(8), Ignacio Vázquez-Garćıa(8), Ali Bashashati(7), Damian Yap(7)